SEI Investments’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,855
Closed -$228K 2689
2023
Q2
$228K Sell
4,855
-4,246
-47% -$211K ﹤0.01% 2435
2023
Q1
$382K Buy
+9,101
New +$391K ﹤0.01% 2236
2022
Q4
Sell
-8,207
Closed -$321K 2659
2022
Q3
$321K Buy
8,207
+1,035
+14% +$40K ﹤0.01% 2278
2022
Q2
$231K Buy
+7,172
New +$240K ﹤0.01% 2435
2021
Q3
Sell
-54,860
Closed -$3.13M 2619
2021
Q2
$3.13M Buy
54,860
+3,013
+6% +$213K 0.01% 1307
2021
Q1
$3.94M Buy
51,847
+1,623
+3% +$133K 0.01% 1148
2020
Q4
$4.33M Buy
50,224
+13,585
+37% +$1M 0.01% 1040
2020
Q3
$2.24M Buy
36,639
+8,157
+29% +$413K 0.01% 1244
2020
Q2
$1.18M Buy
28,482
+6,482
+29% +$235K ﹤0.01% 1487
2020
Q1
$606K Sell
22,000
-10,739
-33% -$622K ﹤0.01% 1676
2019
Q4
$2.35M Sell
32,739
-31,969
-49% -$3.93M 0.01% 1258
2019
Q3
$9.07M Buy
64,708
+2,029
+3% +$339K 0.02% 641
2019
Q2
$11.5M Buy
62,679
+6,640
+12% +$1.13M 0.04% 516
2019
Q1
$8.9M Buy
56,039
+51,237
+1,067% +$7.42M 0.03% 601
2018
Q4
$641K Buy
4,802
+365
+8% +$41.8K ﹤0.01% 1690
2018
Q3
$622K Sell
4,437
-6,837
-61% -$1.06M ﹤0.01% 1602
2018
Q2
$1.76M Buy
11,274
+11,269
+225,380% +$1.77M 0.01% 1373
2018
Q1
$1K Buy
+5
New +$849 ﹤0.01% 3349
2016
Q4
Sell
-5,702
Closed -$263K 3036
2016
Q3
$263K Buy
5,702
+5,468
+2,337% +$223K ﹤0.01% 1610
2016
Q2
$7K Buy
234
+16
+7% +$534 ﹤0.01% 2339
2016
Q1
$7K Sell
218
-8
-4% -$282 ﹤0.01% 2244
2015
Q4
$13K Sell
226
-5,690
-96% -$282K ﹤0.01% 2181
2015
Q3
$250K Buy
5,916
+901
+18% +$55.5K ﹤0.01% 1550
2015
Q2
$366K Buy
5,015
+125
+3% +$8.04K ﹤0.01% 1269
2015
Q1
$245K Buy
4,890
+4,828
+7,787% +$208K ﹤0.01% 1354
2014
Q4
$2K Buy
+62
New +$2.31K ﹤0.01% 2067

Other funds holding SAGE